Histone deacetylase inhibition alters mRNA expression of cell cycle- and senescence-associated genes in primary equine chondrocytes.

Overview

• This research investigates how inhibiting histone deacetylases (using TSA) affects gene expression related to the cell cycle and cellular aging (senescence) in primary horse cartilage cells (chondrocytes).
• The study explores transcriptional changes that could influence cartilage health, inflammation, and potential therapeutic approaches for cartilage damage.

Background and Importance

• Cellular Senescence: A state where cells stop dividing but remain metabolically active, releasing inflammatory molecules that can damage tissues over time.
• Cartilage and Aging: Senescent chondrocytes contribute to low-grade inflammation in joints, potentially leading to cartilage defects common in older populations.
• Therapeutic Context: Histone deacetylase inhibitors (HDACi) like trichostatin A (TSA) are used to modify cell behavior, including promoting cell differentiation and possibly affecting senescence.

Goals of the Study

• To analyze how TSA-induced histone deacetylase inhibition affects gene expression in equine primary chondrocytes at the 4th cell passage in culture.
• To identify transcriptional changes associated with cell cycle regulation and senescence pathways.
• To evaluate potential protective or detrimental effects of TSA treatment on cartilage cells, considering therapeutic implications.

Key Experimental Approach

• Primary equine chondrocytes cultured in a 2D system up to the 4th passage.
• Treated with a low dose of TSA, a known histone deacetylase inhibitor.
• Transcriptomic analysis performed to assess changes in gene expression profiles.

Main Findings

• Downregulation of Cell Cycle Genes:
  • Reduction in genes related to cell division and proliferation, including those encoding CDK4 (cyclin-dependent kinase 4) and pRb (retinoblastoma protein), which are critical for cell cycle progression.
  • Interestingly, the commonly senescence-associated gene p16INK4a did not show increased expression, indicating a unique senescence profile induced by TSA in these cells.
• Upregulation of Mitochondrial and Proteasome Genes:
  • Genes involved in oxidative phosphorylation (energy production in mitochondria) and proteasome pathways (protein degradation machinery) were increased.
  • This suggests that TSA may help maintain mitochondrial function and protein quality control, potentially protecting chondrocytes from stress.
• FOXO Signaling Pathway Decline:
  • The FOXO family of transcription factors, which is important for cell stress resistance and longevity, showed reduced transcriptional activity.
  • This unexpected decline may influence how chondrocytes respond to stress under TSA treatment.
• Immune-Related Gene Upregulation:
  • Some immune system-related genes were selectively increased in TSA-treated chondrocytes.
  • This could reflect TSA’s role in modulating the senescence-associated secretory phenotype (SASP), potentially affecting inflammation in the cartilage tissue environment.

Implications and Conclusions

• The study enhances understanding of how histone deacetylase inhibition impacts chondrocyte gene expression linked to cell cycle arrest and senescence.
• Downregulation of proliferation genes without typical senescence markers like p16INK4a suggests a unique, potentially reversible senescent state induced by HDACi treatment.
• Increased mitochondrial and proteasomal gene activity may provide beneficial effects by supporting cell maintenance and reducing cellular stress.
• Changes in immune and FOXO signaling highlight complex effects of TSA on cell aging and inflammatory potential.
• These findings contribute to the discussion on the therapeutic potential and risks of using HDAC inhibitors for treating age-related cartilage damage and osteoarthritis.